Shopping Cart
Current evidence · For medical professionals
PRP Therapy for Tendinopathy: Evidence, Applications and Limitations
PRP is studied and used for different tendon disorders. The results cannot be transferred from one tendon to another: the evidence signals for tennis elbow differ from those for Achilles, patellar and rotator cuff tendinopathy.
01“Tendon inflammation” is often too impreciseChronic symptoms are frequently related to tendinopathy rather than a purely acute inflammatory process.
02Evidence depends on the tendonPositive results in one region do not justify a general claim for other tendons.
03PRP is not one standardised productPreparation, cell composition, volume and application protocol vary.
In brief
PRP is a plasma fraction prepared from the patient’s own blood. Platelets release proteins and signalling molecules involved in clotting and tissue responses. Biological plausibility, however, does not prove that PRP reduces pain, structurally repairs a tendon or accelerates return to activity.
For lateral elbow tendinopathy, some randomised trials report longer-term benefits compared with corticosteroid injections, but placebo-controlled comparisons do not consistently confirm superiority. High-quality studies of the Achilles tendon mostly show no additional clinical benefit over placebo. Evidence for patellar and rotator cuff tendinopathy remains conflicting or limited.
Editorial and commercial context: prpmed is a specialist supplier of PRP tubes, centrifuges and accessories, not a treatment provider. Commercial links are marked. This article does not provide individual treatment advice.
Show article contents
01
Is every “tendon inflammation” actually inflammatory?
The everyday term covers several different clinical conditions.
Direct answer
No. Acute tendinitis may include inflammatory components. For persistent symptoms, the broader term tendinopathy is often used because structural, cellular and load-related changes may be involved in addition to inflammation.
Tendinitis
In the narrower sense, an acute inflammatory reaction of the tendon.
Tendinosis
Primarily describes degenerative or structural changes.
Tendinopathy
An umbrella clinical term for tendon pain and impaired function.
Why the distinction matters: PRP data from chronic mid-portion tendinopathy cannot automatically be applied to an acute tendon rupture or an insertional disorder.
02
What is PRP?
PRP is a processed plasma fraction obtained from the patient’s own blood.
Direct answer
Venous blood is collected into an intended tube system and centrifuged. The resulting plasma fraction has a different concentration of platelets and, depending on the system, leukocytes and residual erythrocytes compared with whole blood.
“PRP” is not a globally uniform preparation. Relevant factors include starting blood volume, tube type, anticoagulant, separation gel, centrifugation protocol, harvest zone and activation.
Platelets
Platelets are blood components involved in clotting. After activation, they release various proteins and signalling molecules.
Plasma
Plasma is the liquid component of blood and contains water, proteins, electrolytes and other dissolved substances.
Further reading: PRP treatment: procedure, effects and limitations.
03
Why is PRP studied for tendinopathy?
Research interest is based on a biological rationale, not on guaranteed “tendon repair”.
PRP contains platelet-derived signalling molecules associated in laboratory and tissue models with cell communication, vascular responses and remodelling processes. This led to the hypothesis that local PRP application might influence the biological environment of a chronically altered tendon.
The key limitation: Laboratory findings cannot predict whether a treated person will experience less pain, recover function faster or achieve lasting structural improvement.
Claims such as “PRP repairs the tendon”, “prevents further weakening” or “safely accelerates healing” go beyond the clinical evidence unless they are supported for a specific indication.
04
How should the evidence for different tendons be interpreted?
Results differ by body region, comparator and PRP protocol.
Lateral elbow tendinopathy
Some randomised trials report better medium- to long-term outcomes with PRP than with corticosteroid injections. Placebo-controlled studies, however, do not show consistently clear superiority over saline. Interpretation therefore depends on the comparator and the time point assessed. [1] [2] [3] [4]
Possible signal, but inconsistentAchilles tendinopathy
Placebo-controlled trials found no clinically relevant additional benefit for chronic mid-portion tendinopathy. A large study of acute Achilles tendon rupture also found no advantage in function or quality of life after two years. [5] [6]
No established additional benefitPatellar tendinopathy
A 2019 randomised trial found no benefit of either leukocyte-rich or leukocyte-poor PRP over saline when combined with rehabilitation. In a study published in 2024, all groups improved and the largest clinical improvement was observed in the PRP group. The findings therefore remain conflicting. [7] [8]
Conflicting resultsNo blanket statement that “PRP works for tendon inflammation”: A sound statement must at least specify the tendon, location, duration, comparator and PRP composition.
05
Why do PRP studies reach different conclusions?
PRP is not fully standardised, either technically or biologically.
| Factor | Possible differences | Why it matters |
|---|---|---|
| Diagnosis | Acute or chronic, insertion or mid-portion, partial tear or tendinopathy | Different disorders are sometimes grouped together. |
| PRP composition | Platelet, leukocyte and erythrocyte concentrations | Preparations carrying the same label may be biologically different. |
| Preparation | Tube, anticoagulant, rotor, RCF, run time, single or double spin | Process parameters affect the plasma fraction obtained. |
| Application | Volume, number of applications, ultrasound guidance and target region | Different interventions may all be described as a “PRP injection”. |
| Co-intervention | Exercise, load management, immobilisation or other procedures | Improvement cannot always be attributed to the injection alone. |
| Comparator | Saline, sham treatment, corticosteroid or dry needling | “Better than cortisone” is not the same as “better than placebo”. |
06
How should PRP be integrated into clinical practice?
An injection does not replace a robust diagnosis or a structured rehabilitation plan.
Before deciding
Diagnosis and indication
- Assess symptoms and loading history
- Exclude acute rupture and other causes
- Define tendon region and pathology precisely
- Review previous measures
- Discuss expectations realistically
When planning
Protocol and documentation
- Document the PRP system
- Record preparation parameters
- Describe application technique and target region
- Define the accompanying rehabilitation plan
- Collect outcomes systematically
Professional context: The NICE recommendation was first published in 2013 and migrated to HealthTech Guidance HTG299 in January 2026 without content changes. It continues to regard the efficacy of autologous blood and PRP injections for tendinopathy as inadequately established and calls for special arrangements for governance, consent and outcome collection. [11]
07
Which risks and limitations should be discussed?
“Autologous” does not automatically mean risk-free.
Pain, irritation, swelling or bruising may occur after local PRP application. General risks of invasive procedures also include infection, bleeding, injury to adjacent structures and inaccurate placement.
Medical limitations
- No guaranteed pain reduction
- No guaranteed structural healing
- No uniform benefit across all tendons
- No generally accepted standard number of applications
- No blanket acceleration of return to sport
Process-related risks
- Incompatible materials
- Inadequate asepsis
- Non-reproducible preparation
- Missing product characterisation
- Unverified transfer of RPM values between systems
08
Which components belong to a technical PRP workflow?
Products must be selected according to intended purpose, instructions for use and compatibility.
Blood collection, tube system, centrifuge, rotor, process parameters and sterile downstream handling should be considered as one connected workflow.
International B2B shipping
PRP equipment for practices in Germany and abroad
prpmed supports professional PRP workflows and supplies business customers in Germany as well as in other European and selected international markets.
Availability depends on the destination country, product category and applicable import and use requirements. Shipments to non-EU countries may involve additional customs, tax and import obligations.
International availability is not a statement that a product is medically suitable for a specific tendon disorder or treatment.
Commercial links: The following links lead to prpmed shop and professional pages. They are not a recommendation for a specific tendon disorder.
Practice equipmentPRP starter setsCombinations of centrifuge, tubes and consumables.View starter setsPreparationPRP tubesTube systems with different additives and technical characteristics.View PRP tubesDevice technologyCentrifugesDevices for professional sample and PRP workflows.Compare centrifugesBlood collectionBlood collection accessoriesSafety and butterfly systems for professional blood collection.View accessoriesCalculation aidRCF/RPM calculatorConversion using the actual rotor radius.Open calculatorProfessional knowledgeWhat are PRP tubes?Professional article on additives, intended purpose and system differences.Read article
Technical note: RPM alone does not describe the force acting on the sample. RCF depends on rotational speed and rotor radius. Manufacturer instructions and the intended protocol remain decisive.
09
Frequently asked questions about PRP for tendon disorders
Concise answers without individual treatment advice.
Can PRP reliably repair a damaged tendon?
No. Guaranteed structural repair has not been clinically established. Studies mainly assess pain, function and sometimes imaging.
Does PRP work for every tendon disorder?
No. Evidence depends on the tendon. High-quality placebo-controlled studies of Achilles tendinopathy do not show an established additional benefit.
Where is the evidence most favourable?
Lateral elbow tendinopathy has a comparatively large number of randomised studies. Some report medium- to long-term benefits over corticosteroids, while placebo-controlled studies do not show consistently clear superiority over saline.
Why is the Achilles tendon particularly critical?
Several placebo-controlled studies of chronic mid-portion tendinopathy found no relevant additional benefit.
Is leukocyte-rich or leukocyte-poor PRP better?
There is no universally valid answer. The optimal composition may depend on tissue, clinical question and protocol.
How many PRP applications are required?
There is no accepted standard number for all tendinopathies. Studies use different single- and multiple-application protocols.
Is ultrasound guidance required?
Requirements depend on the target structure, technique, professional competence and protocol.
Can PRP replace rehabilitation?
No. PRP should not be considered separately from diagnosis, load management and rehabilitation.
Is PRP risk-free because it is autologous?
No. Risks arise from blood collection, preparation and injection.
Which technical details should be documented?
Tube system, starting volume, anticoagulant, centrifuge, rotor, RCF, run time, harvested volume, harvest fraction and application protocol.
10
Selected scientific sources
Randomised trials and professional guidelines used for interpretation.
Source status: Randomised trials up to July 2026 and the 2025 AAOS guideline were considered. The NICE recommendation was originally published in 2013 and transferred to the current guidance structure in 2026 without content changes.
- Gosens T. et al.: Ongoing positive effect of platelet-rich plasma versus corticosteroid injection in lateral epicondylitis: a double-blind randomized controlled trial with 2-year follow-up. American Journal of Sports Medicine, 2011. PubMed PMID 21422467
- Krogh T. P. et al.: Treatment of lateral epicondylitis with platelet-rich plasma, glucocorticoid, or saline: a randomized, double-blind, placebo-controlled trial. American Journal of Sports Medicine, 2013. PubMed PMID 23328738
- Dejnek M. et al.: Comparative Efficacy of Platelet-Rich Plasma, Corticosteroid, Hyaluronic Acid, and Placebo (Saline) Injections in Patients with Lateral Elbow Tendinopathy: A Randomized Controlled Trial. Journal of Clinical Medicine, 2025. PubMed PMID 39860479
- Wilson J. J. et al.: A Randomized Controlled Trial of 1-Year Clinical Outcomes of a Single Platelet-Rich Plasma Injection Versus Corticosteroid for the Treatment of Lateral Elbow Tendinopathy. Orthopaedic Journal of Sports Medicine, 2026. PubMed PMID 41552627
- de Vos R. J. et al.: Platelet-rich plasma injection for chronic Achilles tendinopathy: a randomized controlled trial. JAMA, 2010. PubMed PMID 20068208
- Keene D. J. et al.: Platelet-rich plasma injection for acute Achilles tendon rupture: two-year follow-up of a randomized, placebo-controlled trial. Bone & Joint Journal, 2022. PubMed PMID 36317349
- Scott A. et al.: Platelet-Rich Plasma for Patellar Tendinopathy: A Randomized Controlled Trial of Leukocyte-Rich PRP or Leukocyte-Poor PRP Versus Saline. American Journal of Sports Medicine, 2019. PubMed PMID 31038979
- van der Heijden R. A. et al.: Platelet-rich plasma for patellar tendinopathy: a randomized controlled trial correlating clinical outcomes and quantitative imaging. Radiology Advances, 2024. PubMed PMID 41059395
- Kwong C. A. et al.: Platelet-Rich Plasma in Patients With Partial-Thickness Rotator Cuff Tears or Tendinopathy Leads to Significantly Improved Short-Term Pain Relief and Function Compared With Corticosteroid Injection: A Double-Blind Randomized Controlled Trial. Arthroscopy, 2021. PubMed PMID 33127554
- American Academy of Orthopaedic Surgeons (AAOS).: Management of Rotator Cuff Injuries – Clinical Practice Guideline. 2025. AAOS guideline
- National Institute for Health and Care Excellence (NICE).: Autologous blood injection for tendinopathy. HealthTech Guidance HTG299; first published 2013, migrated in 2026 without content changes. NICE Guidance
Technical equipment for professional PRP workflows
prpmed supplies tube systems, centrifuges, blood collection accessories and starter sets for professional users.
Commercial note: Product selection must follow the intended purpose, instructions for use, system compatibility and the professional requirements of the practice.
Medical and legal notice: This article is primarily intended for medical professionals and provides a general literature-based overview. It does not contain an individual diagnosis, treatment recommendation, promise of success or procedural instruction. The individual medical assessment, current professional guidelines, intended purpose and instructions for use of the products, and applicable legal and professional rules remain decisive.